Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer

被引:1
|
作者
Shi, X. [1 ]
Liu, X. [1 ]
Wang, Y. [2 ]
Lu, D. [1 ]
Dong, X. [1 ]
Feng, S. [1 ]
Cai, K. [1 ]
机构
[1] Nanfang Hosp, Thorac Surg, Guangzhou, Guangdong, Peoples R China
[2] Nanfang Hosp, Oncol, Guangzhou, Guangdong, Peoples R China
关键词
small cell lung cancer; survival; Angiogenesis Inhibitors;
D O I
10.1016/j.jtho.2018.08.1384
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.12-08
引用
收藏
页码:S793 / S793
页数:1
相关论文
共 50 条
  • [41] A Systematic Review and Meta-Analysis of Early and Late Survival Following Anti-Cancer Therapies for Small Cell Lung Cancer
    Jones, G.
    Elimian, K.
    Baldwin, D.
    Mckeever, T.
    Hubbard, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S577 - S578
  • [42] Therapeutic vaccination for non-small-cell lung cancer: a meta-analysis
    Ding, Mei
    Yang, Jiong
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [43] Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
    Zhu, Yan-Juan
    Zhang, Hai-Bo
    Liu, Yi-Hong
    Bai, Jian-Ping
    Li, Yong
    Liu, Li-Rong
    Qu, Yan-Chun
    Qu, Xin
    Chen, Xian
    ONCOLOGY LETTERS, 2017, 14 (01) : 655 - 664
  • [44] Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis
    Zhang, Junfang
    Tang, Xuan
    Zhang, Wenbo
    Xu, Ying
    Zhang, Heng
    Fan, Yu
    CLINICAL NUTRITION, 2024, 43 (07) : 1618 - 1625
  • [45] Bayesian network meta-analysis of efficacy and safety of neoadjuvant therapy for non-small-cell lung cancer
    Ren, Yijiu
    Tang, Hai
    Zhang, Jie
    She, Yunlang
    Sun, Xiaoting
    Xie, Dong
    Chen, Chang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [46] Risk Factors for Brain Metastasis in Patients with Small Cell Lung Cancer: A Systematic Review and Meta-analysis
    Zeng, H.
    Zheng, D.
    Witlox, W.
    Levy, A.
    Traverso, A.
    Kong, F. -M. S.
    Houben, R.
    De Ruysscher, D.
    Hendriks, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S532 - S532
  • [47] Comparative effectiveness and toxicity of radiotherapy regimens in limited stage small cell lung cancer: A network meta-analysis
    Zhou, Jiupeng
    Guo, Hui
    Zhang, Yongfeng
    Liu, Heng
    Dou, Quanli
    CANCER MEDICINE, 2022, 11 (22): : 4214 - 4224
  • [48] A Bayesian network meta-analysis of ALK inhibitor treatments in patients with ALK-positive non-small cell lung cancer
    Zheng, Bei
    Jiang, Hong
    Yang, Wenjuan
    Li, Ying
    Liang, Bingqing
    Zhu, Jun
    Chen, Nanmei
    Chen, Miao
    Zhang, Meiling
    CANCER MEDICINE, 2023, 12 (15): : 15983 - 15997
  • [49] Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis
    Li, Xue
    Wang, Fang
    Jia, Huijun
    Lian, Zhen
    Ren, Kai
    Yuan, Zhiyong
    Wang, Ping
    Zhao, Lujun
    FUTURE ONCOLOGY, 2022, 18 (27) : 3055 - 3065
  • [50] Immune checkpoint inhibitors for first-line treatment of advanced non-small-cell lung cancer: A systematic review and network meta-analysis
    Peng, Tzu-Rong
    Lin, Hung-Hong
    Tsai, Fang-Pei
    Wu, Ta-Wei
    THORACIC CANCER, 2021, 12 (21) : 2873 - 2885